Crosstalk between the innate immune system and selective autophagy in hepatitis B virus infection.
BRET
hepatitis B virus
interferon
selective autophagy
xenophagy
Journal
Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
pubmed:
6
4
2022
medline:
4
8
2022
entrez:
5
4
2022
Statut:
ppublish
Résumé
Although the involvement of macroautophagy/autophagy in hepatitis B virus (HBV) infection has become clearer recently, whether selective autophagy plays an important role in suppressing HBV remains uncertain. We recently found that LGALS9 (galectin 9) is an interferon (IFN)-inducible protein involved in the suppression of HBV replication. Expression of LGALS9 in HBV-infected cells causes the formation of cytoplasmic puncta that degrade the HBV core protein (HBc) in conjunction with RSAD2/viperin, another IFN-inducible protein. LGALS9 binds to HBc via RSAD2 and promotes the autoubiquitination of RNF13 (ring finger protein 13) to recruit SQSTM1/p62, resulting in the formation of LC3-positive autophagosomes that degrade HBc. Both LGALS9 and RSAD2 are encoded by IFN-stimulated genes that act synergistically to induce HBc proteolysis in HBV-infected hepatocytes in an IFN-dependent manner. These results reveal a crosstalk mechanism between the innate immune system and selective autophagy during viral infection.
Identifiants
pubmed: 35380913
doi: 10.1080/15548627.2022.2059747
pmc: PMC9450967
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
2006-2007Commentaires et corrections
Type : CommentOn
Références
Nat Commun. 2022 Jan 27;13(1):531
pubmed: 35087074